Cellular uptake of PET tracers of glucose metabolism and hypoxia and their linkage. - Wikidata - wikimedia - TriplyDB

Cellular uptake of PET tracers of glucose metabolism and hypoxia and their linkage.

Cellular uptake of PET tracers of glucose metabolism and hypoxia and their linkage.

http://www.wikidata.org/entity/Q39953573

about

HypoxamiRs and cancer: from biology to targeted therapy High 18F-FDG uptake in microscopic peritoneal tumors requires physiologic hypoxia.In vivo identification and specificity assessment of mRNA markers of hypoxia in human and mouse tumors PET radiopharmaceuticals for imaging of tumor hypoxia: a review of the evidence (18)F-fluorodeoxyglucose uptake and tumor hypoxia: revisit (18)f-fluorodeoxyglucose in oncology application.Systematic analysis of 18F-FDG PET and metabolism, proliferation and hypoxia markers for classification of head and neck tumors Optimizing hypoxia detection and treatment strategies.Significant impact of different oxygen breathing conditions on noninvasive in vivo tumor-hypoxia imaging using [¹⁸F]-fluoro-azomycinarabino-furanoside ([¹⁸F]FAZA).Micro Regional Heterogeneity of 64Cu-ATSM and 18F-FDG Uptake in Canine Soft Tissue Sarcomas: Relation to Cell Proliferation, Hypoxia and Glycolysis.Tumour microenvironment heterogeneity affects the perceived spatial concordance between the intratumoural patterns of cell proliferation and 18F-fluorothymidine uptake Molecular imaging of hypoxia with radiolabelled agents Pharmacokinetics, metabolism, biodistribution, radiation dosimetry, and toxicology of (18)F-fluoroacetate ((18)F-FACE) in non-human primates Imaging tumour physiology and vasculature to predict and assess response to heat.PET-CT for radiotherapy treatment planning and response monitoring in solid tumors.Molecular imaging-based dose painting: a novel paradigm for radiation therapy prescription.Molecular PET imaging for biology-guided adaptive radiotherapy of head and neck cancer.Dose painting based on tumor uptake of Cu-ATSM and FDG: a comparative study.Results from 11C-metformin-PET scans, tissue analysis and cellular drug-sensitivity assays questions the view that biguanides affects tumor respiration directly.Impact of Oxygenation Status on 18F-FDG Uptake in Solid Tumors.Noncoding RNAs in Regulation of Cancer Metabolic Reprogramming.Imaging of Tumor Metabolism Using Positron Emission Tomography (PET).Hyperpolarized magnetic resonance spectroscopy for assessing tumor hypoxia.Reprogramming of tumor metabolism by targeting mitochondria improves tumor response to irradiation.Revisit 18F-fluorodeoxyglucose oncology positron emission tomography: "systems molecular imaging" of glucose metabolism.An exploratory study of volumetric analysis for assessing tumor response with (18)F-FAZA PET/CT in patients with advanced non-small-cell lung cancer (NSCLC).Uptake of [(18)F]EF5 as a Tracer for Hypoxic and Aggressive Phenotype in Experimental Head and Neck Squamous Cell Carcinoma.Dose escalation to high-risk sub-volumes based on non-invasive imaging of hypoxia and glycolytic activity in canine solid tumors: a feasibility study.Monitoring the effects of bevacizumab beyond progression in a murine colorectal cancer model: a functional imaging approach.FDG-PET reproducibility in tumor-bearing mice: comparing a traditional SUV approach with a tumor-to-brain tissue ratio approach.Reproducibility of functional volume and activity concentration in 18F-FDG PET/CT of liver metastases in colorectal cancer.Prognostic value of tumour blood flow, [¹⁸F]EF5 and [¹⁸F]FDG PET/CT imaging in patients with head and neck cancer treated with radiochemotherapy.Advantage of FMISO-PET over FDG-PET for predicting histological response to preoperative chemotherapy in patients with oral squamous cell carcinoma.Monitoring hypoxia and vasculature during bevacizumab treatment in a murine colorectal cancer model.PET imaging of tumor hypoxia using 18F-labeled pimonidazole.Imaging of hypoxia with 18F-FAZA PET in patients with locally advanced non-small cell lung cancer treated with definitive chemoradiotherapy.Pharmacokinetic analysis of [18F]FAZA in non-small cell lung cancer patients.Role of FDG-PET as a biological marker for predicting the hypoxic status of tongue cancer.Assessing hypoxia in animal tumor models based on pharmocokinetic analysis of dynamic FAZA PET.

P2860

Q26863298-018E0600-D117-4058-9BED-A9660CA05D03 Q33547295-5FCA2E92-BA49-4260-BFAC-8A738C97736E Q33816406-9E4A0778-F793-4B4C-BA1D-13BE1FA795BA Q33818999-B19357E3-7AB2-41E3-B8BC-B022425CD5FC Q33912335-4525757E-E42F-45F1-BE94-F8EAAA3C0B06 Q35103263-930B7BDC-CC66-4C6E-B92B-F4CF2F61CA17 Q35195185-387F20A0-0127-40A0-81BD-8FF49CB16CDD Q35769008-526052CB-2EEB-4514-87D8-942A1E3C541A Q35821298-D905EEBA-C021-47E3-AA17-A8EBF4B5F2C8 Q36070106-9C8509F6-5165-4F0F-9712-A23861F162A3 Q37378239-7277ADDA-E2F0-45D3-BA13-31E943F8394B Q37518179-249C9FF1-AEA8-4B94-9193-9729116F1B9E Q37730090-163D6F96-A6E2-44CE-9F20-8826AE1EB20A Q37832131-F059ED4B-9FF4-495C-8DEB-8BC2CFD22657 Q37847721-79749972-8767-439D-B6C6-516882EAE6CB Q38134094-F6021141-6861-4699-A6C7-E4A81823D6D7 Q38418282-4EE55B8A-117C-41B6-8C56-214F68B8E077 Q38637111-46487C66-9A48-4F3B-B461-071EFE66F946 Q38802059-2C9053DA-9DE9-4C56-88E7-38CAD54A1DC9 Q38885481-7977B8E5-F12A-4F21-AD37-CFDF55FF9D6E Q38936273-3A9804F2-92A8-474F-AC47-3A677A608E21 Q38967249-0B3E28F1-3AE2-4676-9265-38C20F3CAB02 Q38976950-35E52E74-2F21-49C5-9110-B18C30704EC3 Q39237778-189EFDE7-E58C-4CE0-9146-9E76824719D9 Q40303887-80B45485-EB46-49F4-AA60-6B529E37461A Q41871576-502896BB-D3E9-4340-A53C-FE5EF3D2AC86 Q42907283-3BA33FE1-D7AC-473B-9DBB-847731A2331C Q43617653-BD5D2D61-AC6C-4C8B-8770-18E3AC880C1D Q47341443-F77DF72F-C66A-4A3E-A719-08A58D09E1CC Q51327327-8BD963E6-913D-4B64-8014-91377E94BFA8 Q53063794-C12C19CA-84C5-4B77-BCB8-9F2C3B3AA286 Q53064658-03BA92E1-8D17-4659-B455-928EEC88DE18 Q53071720-1CD6A790-0E66-4937-A295-74798CC92940 Q53097892-63B86875-6176-469D-B5B7-683EE44BF9CF Q53101024-8DAEA4C1-0647-4BC6-8CEA-B4B9BC2CCFF1 Q53120502-1835EF84-023D-466F-AD09-1791686E013B Q53193315-97D10F3B-133A-4512-A8D3-1AC427D06545 Q53273186-0FE00D3E-2B8E-44BF-ADDB-D8C37323163D

P2860

Cellular uptake of PET tracers of glucose metabolism and hypoxia and their linkage.

http://www.wikidata.org/entity/Q39953573

description

2008 nî lūn-bûn

@nan

2008年の論文

@ja

2008年学术文章

@wuu

2008年学术文章

@zh-cn

2008年学术文章

@zh-hans

2008年学术文章

@zh-my

2008年学术文章

@zh-sg

2008年學術文章

@yue

2008年學術文章

@zh

2008年學術文章

@zh-hant

name

Cellular uptake of PET tracers of glucose metabolism and hypoxia and their linkage.

@en

Cellular uptake of PET tracers of glucose metabolism and hypoxia and their linkage.

@nl

type

label

Cellular uptake of PET tracers of glucose metabolism and hypoxia and their linkage.

@en

Cellular uptake of PET tracers of glucose metabolism and hypoxia and their linkage.

@nl

prefLabel

Cellular uptake of PET tracers of glucose metabolism and hypoxia and their linkage.

@en

Cellular uptake of PET tracers of glucose metabolism and hypoxia and their linkage.

@nl

P1433

Q39953573-0F7AF061-7E5D-46E2-B66B-43662C9CF289

P1476

Q39953573-64A6346B-CE05-4275-B312-3CF75B101414

P2093

Q39953573-48E7F35D-CBE1-4E48-B55B-11DFAD206FF9

Q39953573-673B9977-65F0-4D7C-8031-08504B14BDF0

Q39953573-84F88B08-5875-4816-9BFA-3A37FFEC3A2D

Q39953573-BA290D4E-014E-4997-92D2-CFF8F107DC11

P2860

Q39953573-0635384E-68D7-4200-BBAA-298FA84D1B21

Q39953573-3174C5E5-CA01-4E57-A211-E94AB24E58C4

Q39953573-83139A0A-FBDA-4577-BAFD-F45DFF0367C3

Q39953573-D095534F-F40C-4634-86EA-7A279FA26503

Q39953573-D2E4671B-6833-4A87-98AC-10D6D49803F4

Q39953573-E47455C0-7B2D-405C-B386-43163ED9A4ED

P2888

Q39953573-16AA602B-AA38-4157-BAAC-3263BAEC6B8D

P304

Q39953573-53201BA0-B364-442A-A1B5-D301B53D294E

P31

Q39953573-35AD9DB3-A5B6-45C0-A3CC-C750F64D6642

P356

Q39953573-4C1EC906-D949-4968-A199-CE38376122B9

P433

Q39953573-F6AD22E1-9CE4-4648-BFA5-1D33DD564EA5

P478

Q39953573-4FAE74B2-9E0B-491E-92BF-19CE6CA1590C

P50

Q39953573-85A37E7C-5E6C-438A-B98B-6EB8C957E2F7

Q39953573-95ED3172-6AFD-4C9E-81D7-5ED1BDA93658

P577

Q39953573-DE4718D1-7E4A-409E-B91B-C6C9431C3231

P698

Q39953573-4B108003-64F1-4520-BE68-B97AA5BCC269

P921

Q39953573-4d818f08-6715-4d19-9aae-c5550bd49ce8

Q39953573-CF45AD61-BA59-4317-9627-2A3F85584FEB

Q39953573-D17708B0-6820-4B12-89E0-60573DCD1489

P356

S00259-008-0888-9

P1433

European Journal of Nuclear Medicine and Molecular Imaging

P1476

Cellular uptake of PET tracers of glucose metabolism and hypoxia and their linkage

@en

P2093

Albert van der Kogel

http://www.w3.org/2001/XMLSchema#string

Jens Overgaard

http://www.w3.org/2001/XMLSchema#string

Morten Busk

http://www.w3.org/2001/XMLSchema#string

Steen Jakobsen

http://www.w3.org/2001/XMLSchema#string

P2860

Dependence of FDG uptake on tumor microenvironment.

Imaging hypoxia in xenografted and murine tumors with 18F-fluoroazomycin arabinoside: a comparative study involving microPET, autoradiography, PO2-polarography, and fluorescence microscopy.

Proliferation-dependent changes in amino acid transport and glucose metabolism in glioma cell lines.

[(18)F]FMISO and [(18)F]FDG PET imaging in soft tissue sarcomas: correlation of hypoxia, metabolism and VEGF expression.

Transient changes in permeability in HeLa and L cells during detachment from a substrate.

Prediction of outcome in head-and-neck cancer patients using the standardized uptake value of 2-[18F]fluoro-2-deoxy-D-glucose.

P2888

s00259-008-0888-9

P304

2294-2303

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00259-008-0888-9

http://www.w3.org/2001/XMLSchema#string

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

35

http://www.w3.org/2001/XMLSchema#string

P50

Michael R. Horsman

P577

2008-08-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

18682937

http://www.w3.org/2001/XMLSchema#string

P921